Munro Partners
Thematic global growth equities investor
Munro Partners is a global investment management partnership specialising in growth equities. Founded in 2016 by an award-winning team with a proven track record of delivering strong returns, Munro Partners are a majority owned and controlled by employees. Their proprietary investment process, combined with a global network and deep industry expertise, positions their portfolios to capitalise on the key structural changes occurring in our world today. Fully aligned with investors' goals, the team invests in Munro Partners' products alongside clients. Their partnership is Australian-domiciled, with offices in Melbourne and Toronto, Canada.
https://www.munropartners.com.au/
Related Insights
Magellan Global Opportunities Quarterly Update July 2026
Portfolio Managers Alan Pullen and Ryan Joyce of Magellan Investment Partners discuss the key drivers behind strong global equity market returns, including the receding risk from high energy prices and the surge in semiconductor and data centre supply chain stocks.
Understanding how breast cancer begins
Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.
Mapping the surface of pancreatic cancer cells
Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.
Making early cerebral palsy screening more accessible
Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.
Supporting babies at high risk of cerebral palsy from the very beginning
Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.
Accelerating CAR-T cell therapies for patients in need
Bringing innovative cancer therapies closer to patients.
Building the foundations for faster progress against brain cancer
Uniting researchers, clinicians and patients to accelerate research and improve patient care.
Understanding spinal cord injury recovery
The world's first molecular map of spinal cord injury across time and injury levels
Giving families living with rare diseases the answers they need
Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.
Understanding fatigue in young people with Charcot-Marie-Tooth disease
Developing a tool to improve understanding, research and care.
Improving care for adults with motor neuron diseases
Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.
Improving the diagnosis of muscle disorders using advanced genetic testing
Focused on improving the efficiency and accuracy of diagnosing muscle disorders.
Targeting the drivers of cancer growth
Exploring how extrachromosomal DNA (ecDNA) drives cancer growth, spread and treatment resistance.
Protecting the heart when every minute matters
Investigating a new treatment to reduce heart damage after heart attacks
Harnessing the power of stem cell technology
Developing cell therapies for patients with blood diseases
The Future of Pain Management
Enhancing healthcare professionals' ability to deliver better pain management, now and into the future.
There are no bears in Taipei: what a research trip revealed about the AI infrastructure buildout
What happens when you spend two weeks meeting the companies building the AI revolution? CIO Nick Griffin and Investment Analyst Jean Huang share their biggest insights from Taiwan.
Solving the genetic causes of autoimmune diseases
Mapping hundreds of risk markers to better understand how these diseases develop and progress
Advancing treatment options for type 1 diabetes
Improving blood glucose and reducing insulin needs.
Revealing what drives PSP
Mapping the biological changes behind progressive supranuclear palsy in the brain.
Rethinking Osteoarthritis
Building new insights into one of Australia's most common and disabling conditions.
A new approach to Parkinson’s Disease
Exploring nerve stimulation as a potential treatment.
Unlocking the mysteries of the human brain
The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.
Revolutionising Diabetes Care
Improving diabetes care has the potential to transform individual health outcomes while strengthening the wellbeing of entire communities.
Next generation CAR T-cell therapy for cancer
The Call Lab at WEHI is pioneering innovative approaches to find this ‘goldilocks zone’, making CAR T-cell therapy safer and more effective.
